⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Biomedica and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Biomedica
↗Munich, Germany
Biomedica is a pharmaceutical and biotechnology services company specialized in the commercialization of rare disease products. The company focuses on providing strategic market access, regulatory guidance, and commercialization pathways to help innovative biotech companies expand their presence into underserved and emerging markets, including over 25 countries across Europe, Asia, and the Middle East.
Beyond market access, the company leverages its expertise to support patient identification for clinical trials (Phase 2/3) and provides comprehensive solutions for the distribution of orphan and ultra-orphan drugs. Their mission is to ensure healthcare equity and improve patient access to essential medicines globally.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Rare Disease Commercialization / Market Access
SIZE & FINANCIALS
Employees:51-200
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercialization partner for external assets
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:MassBio (Member)
COMPETITION
Position:Niche Player
LEADERSHIP
Key Executives:
Ludovit Jurecek - EVP | COO/CMO
Stan Filippin - EVP | Business Development
LINKS
Website:biomedica.bio
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Biomedica. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.